[go: up one dir, main page]

PL1941026T3 - Sposoby wytwarzania białek przy użyciu związków przeciwstarzeniowych - Google Patents

Sposoby wytwarzania białek przy użyciu związków przeciwstarzeniowych

Info

Publication number
PL1941026T3
PL1941026T3 PL06844211T PL06844211T PL1941026T3 PL 1941026 T3 PL1941026 T3 PL 1941026T3 PL 06844211 T PL06844211 T PL 06844211T PL 06844211 T PL06844211 T PL 06844211T PL 1941026 T3 PL1941026 T3 PL 1941026T3
Authority
PL
Poland
Prior art keywords
methods
protein production
senescence compounds
senescence
compounds
Prior art date
Application number
PL06844211T
Other languages
English (en)
Inventor
Yen-Tung Luan
Wenge Wang
Paul Thoday
Denis Drapeau
Judy Chou
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1941026(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL1941026T3 publication Critical patent/PL1941026T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
PL06844211T 2005-10-24 2006-10-24 Sposoby wytwarzania białek przy użyciu związków przeciwstarzeniowych PL1941026T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72957305P 2005-10-24 2005-10-24
PCT/US2006/041256 WO2007050498A2 (en) 2005-10-24 2006-10-24 Methods of protein production using anti-senescence compounds
EP06844211.0A EP1941026B1 (en) 2005-10-24 2006-10-24 Methods of protein production using anti-senescence compounds

Publications (1)

Publication Number Publication Date
PL1941026T3 true PL1941026T3 (pl) 2014-12-31

Family

ID=37873105

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06844211T PL1941026T3 (pl) 2005-10-24 2006-10-24 Sposoby wytwarzania białek przy użyciu związków przeciwstarzeniowych

Country Status (23)

Country Link
US (1) US20070110743A1 (pl)
EP (1) EP1941026B1 (pl)
JP (2) JP2009512459A (pl)
KR (1) KR101402634B1 (pl)
CN (1) CN101297027B (pl)
AR (1) AR058140A1 (pl)
AU (1) AU2006306433B2 (pl)
BR (1) BRPI0617744A2 (pl)
CA (1) CA2627003C (pl)
CR (1) CR9897A (pl)
DK (1) DK1941026T3 (pl)
EC (1) ECSP088395A (pl)
ES (1) ES2485374T3 (pl)
IL (1) IL190550A (pl)
NI (1) NI200800111A (pl)
NO (1) NO20081622L (pl)
PE (1) PE20070796A1 (pl)
PL (1) PL1941026T3 (pl)
PT (1) PT1941026E (pl)
RU (1) RU2491347C2 (pl)
SI (1) SI1941026T1 (pl)
TW (1) TW200736397A (pl)
WO (1) WO2007050498A2 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2041270T3 (da) 2006-07-13 2014-01-27 Wyeth Llc Fremstilling af glycoproteiner
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
KR20110091678A (ko) * 2008-10-20 2011-08-12 아보트 러보러터리즈 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제
EP2464739B1 (en) 2009-08-14 2016-01-13 Basf Se Methods in cell cultures, and related inventions, employing certain additives
SG187198A1 (en) 2010-08-05 2013-03-28 Amgen Inc Dipeptides to enhance yield and viability from cell cultures
EP2611904A2 (en) * 2010-08-31 2013-07-10 Friesland Brands B.V. Culture medium for eukaryotic cells
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TW201247874A (en) * 2011-05-25 2012-12-01 United Biomedical Inc Method for producing the activity of bone activating protein
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
BR112015004467A2 (pt) 2012-09-02 2017-03-21 Abbvie Inc método para controlar a heterogeneidade de proteínas
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
CN105189531B (zh) * 2013-03-13 2020-02-21 安特易斯有限公司 用于皮肤复新的肽及其使用方法
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
EP3712252A1 (en) * 2013-03-15 2020-09-23 F. Hoffmann-La Roche AG Cell culture compositions with antioxidants and methods for polypeptide production
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US10376582B2 (en) 2013-10-16 2019-08-13 Outlook Therapeutics, Inc. Buffer formulations for enhanced antibody stability
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN104398398A (zh) * 2014-10-27 2015-03-11 陈少威 一种细胞量子动力素(平衡剂)及其使用方法
MA40864A (fr) * 2014-10-31 2017-09-05 Biogen Ma Inc Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
WO2016118707A1 (en) 2015-01-21 2016-07-28 Oncobiologics, Inc. Modulation of charge variants in a monoclonal antibody composition
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法（一）
JP2018536404A (ja) * 2015-11-09 2018-12-13 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｃｈｏ細胞において産生したポリペプチドの品質特性を操作する方法
EP3400242A1 (en) * 2016-01-06 2018-11-14 Oncobiologics, Inc. Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition
AU2017213775A1 (en) 2016-02-03 2018-08-16 Outlook Therapeutics, Inc. Buffer formulations for enhanced antibody stability
KR20240149973A (ko) * 2017-10-16 2024-10-15 리제너론 파마슈티칼스 인코포레이티드 세포 배양에서 공정 변수를 제어하기 위한 원위치 라만 분광법 시스템 및 방법
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
WO2025053166A1 (ja) * 2023-09-05 2025-03-13 味の素株式会社 培地組成物
WO2025142807A1 (ja) * 2023-12-25 2025-07-03 武田薬品工業株式会社 細胞の培養方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE10399023I2 (de) * 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
EP0571390B1 (en) 1990-11-23 2000-03-08 Peptech Limited The delay, prevention and/or reversal of cell senescence
EP0590058B1 (en) * 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
RU2245365C2 (ru) * 1994-01-03 2005-01-27 Генентек Инк. Тромбопоэтин
US5830761A (en) * 1995-06-07 1998-11-03 Genetics Institute, Inc. Medium and methods for culturing mammalian cho cells
RU2134120C1 (ru) * 1995-06-26 1999-08-10 Безруков Михаил Васильевич Средство для стабилизации пептидной связи в белковом препарате
CA2229043C (en) * 1995-08-18 2016-06-07 Morphosys Gesellschaft Fur Proteinoptimierung Mbh Protein/(poly)peptide libraries
JP4306813B2 (ja) * 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
DE69738539T2 (de) * 1996-12-03 2009-03-26 Amgen Fremont Inc. Vollkommen humane Antikörper die EGFR binden
US20030040095A1 (en) * 2001-03-16 2003-02-27 Achille Arini Method for the production of pharmaceutically active recombinant proteins
AR035867A1 (es) * 2001-04-24 2004-07-21 Innogenetics Nv Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e
BR0317723A (pt) * 2002-12-23 2005-11-22 Bristol Myers Squibb Co Processo de cultura de células de mamìfero para a produção de proteìna
AU2004286938B2 (en) * 2003-10-27 2011-06-30 Wyeth Removal of high molecular weight aggregates using hydroxyapatite chromatography
WO2005064013A1 (en) 2003-12-23 2005-07-14 Bart Janssen The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy
US7294484B2 (en) * 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
US7300773B2 (en) * 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
US7426440B2 (en) * 2004-09-24 2008-09-16 Nutritional Bioscience Ltd. Repair and protection factor scoring method for bioactive agents

Also Published As

Publication number Publication date
IL190550A0 (en) 2008-11-03
WO2007050498A2 (en) 2007-05-03
IL190550A (en) 2017-01-31
RU2008113220A (ru) 2009-12-10
BRPI0617744A2 (pt) 2011-08-02
US20070110743A1 (en) 2007-05-17
RU2491347C2 (ru) 2013-08-27
NI200800111A (es) 2009-03-03
KR20080063365A (ko) 2008-07-03
AU2006306433B2 (en) 2013-04-18
JP2009512459A (ja) 2009-03-26
CN101297027B (zh) 2013-04-03
SI1941026T1 (sl) 2014-07-31
JP5907928B2 (ja) 2016-04-26
NO20081622L (no) 2008-06-18
PT1941026E (pt) 2014-07-31
ES2485374T3 (es) 2014-08-13
JP2013165728A (ja) 2013-08-29
CA2627003C (en) 2018-08-28
PE20070796A1 (es) 2007-08-15
EP1941026A2 (en) 2008-07-09
EP1941026B1 (en) 2014-06-04
DK1941026T3 (da) 2014-07-21
CR9897A (es) 2008-07-29
TW200736397A (en) 2007-10-01
CA2627003A1 (en) 2007-05-03
HK1120552A1 (en) 2009-04-03
WO2007050498A3 (en) 2007-07-12
KR101402634B1 (ko) 2014-06-03
ECSP088395A (es) 2008-05-30
AR058140A1 (es) 2008-01-23
AU2006306433A1 (en) 2007-05-03
CN101297027A (zh) 2008-10-29

Similar Documents

Publication Publication Date Title
IL190550A0 (en) Methods of protein production using anti-senescence compounds
IL201719A0 (en) Methods of protein production using anti-senescence compounds
ZA200711016B (en) Method for production of 1-alkyl-3-phenyluracils
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
ZA200800899B (en) Production of canola protein
IL181587A0 (en) Production of ??-abeta
GB0823478D0 (en) Method of cementing
IL184851A0 (en) Process of producing olefins
IL185757A0 (en) Methods of decreasing calcifcation
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
GB0426160D0 (en) Production of proteins
EP1869192A4 (en) FRAME MIXTURE OF ANTIBODIES
IL184715A0 (en) Process for the preparation of intermediates
IL183106A0 (en) Production of proteins
IL187155A0 (en) Process for production of 4-biphenylazetidin-2-ones
ZA200710066B (en) Process for production of 4-biphenylylazetidin-2-ones
ZA200601910B (en) Process for the preparation of organosilances
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
EP1917231A4 (en) PROCESS FOR THE PRODUCTION OF BROMOPICRIN
PT1912961E (pt) Processo de produção de bepromolina
IL182134A0 (en) Process for production of 2-chloro-4-nitroimidazole
IL177448A0 (en) Methods for protein production
IL189687A0 (en) Process of preparing bromopicrin
GB0509343D0 (en) Biological production of canthaxanthin
PL377916A1 (pl) Sposób wytwarzania optycznie czystego R-(–)-1-okten-3-olu